Peptides for Lupus Nephritis: Targeted Immunotherapy

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Peptide-based therapies are being investigated for lupus nephritis to specifically modulate the autoimmune response and reduce kidney inflammation. These targeted approaches aim to minimize systemic side effects while effectively managing disease activity and preserving renal function.

{" ".join(current_paragraph)}